This is a randomized, 3-period, placebo-controlled, crossover, phase 2 clinical study to examine the efficacy and safety of 2 doses of AD109 vs placebo in patients with mild obstructive sleep apnea.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Hypoxic Burden (HB) Log Transformed - Log10HB[(%*Min)/h]
Timeframe: 1 night (8 hours)
Change in Hypoxic Burden (HB) Raw Values - HB[(%*Min)/h]
Timeframe: 1 night (8 hours)